Recent genome-wide association studies have reported that specific microglial genes, such as CD33, triggering receptor expressed on myeloid cells 2 (TREM2) and human leukocyte antigen—DR isotype, are associated with the susceptibility to late-onset AD. Here, TREM2 is linked to Alzheimer disease.